The initial consultation takes the guesswork out of the process
Tirzepatide and oral contraceptives in obesity: switch to a non-oral contraceptive or barrier method for 4 weeks after initiation or dose escalation
Allow several minutes for complete dissolution, checking visually to ensure no visible particles remain before use
5 Glucagon-like peptide-1 receptor agonists GLP-1R is targeted by GLP-1R agonists, which regulate diabetes and obesity
If qualified, were able to prescribe GLP-1 weight loss medications for as little as $40/per week
CrossRef Postoperative adjuvant TACE combined with lenvatinib and immune checkpoint inhibitors for hepatocellular carcinoma with high recurrence risks: a multicenter retrospective study Ziyue Huang, Taifeng Zhu, Xiaokun Chen, Mingjian Piao, Yang Tan, Chengjie Li, Kai Liu, Shanshan Wang, Lei Zhang, Shunda Du, Chengpei Zhu, Kang Zhou, Xiaobo Yang, Daobing Zeng, Haitao Zhao BMC Cancer .2026;[Epub] CrossRef SLC25A39 binds and modulates PRDX1 to suppress ROS-induced necroptosis in hepatocellular carcinoma Wenxuan Liu, Tianrui Kuang, Keshuai Dong, Man Li, Wenhong Deng, Jia Yu International Immunopharmacology .2026
